NorthWest Biotherapeutics Inc (NWBO)

[MarauderWarlock33]

FDA Advisory Committee has a similar regulations - The Advisor Committee Recommendation to FDA is non binding. If the the committee has concerns about the drug being review still the FDA has to issue the letter of concerns and need to be addressed by the sponsor within 6 days. Also this letter is public information within two days after such meeting. Since there is no such CHM letter by MHRA, it appears to be all good and hope to see approval by MHRA any day now. Happy New Year - it will be wonderful 2026 for NWBO!